Opin vísindi

Fletta eftir höfundi "31619563-5914-43de-a75f-385a36b3692d"

Fletta eftir höfundi "31619563-5914-43de-a75f-385a36b3692d"

Röðun: Raða: Niðurstöður:

  • Icon
    Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both 
    Pfeffer, Paul E; Ali, Nasloon; Murray, Ruth; Ulrik, Charlotte; Tran, Trung N; Maspero, Jorge; Peters, Matthew; Christoff, George C; Sadatsafavi, Mohsen; Torres-Duque, Carlos A; Altraja, Alan; Lehtimäki, Lauri; Papadopoulos, Nikolaos G; Salvi, Sundeep; Costello, Richard W; Cushen, Breda; Heffler, Enrico; Iwanaga, Takashi; Al-Ahmad, Mona; Larenas-Linnemann, Désirée; Kuna, Piotr; Fonseca, João A; Al-Lehebi, Riyad; Rhee, Chin Kook; Perez-de-Llano, Luis; Perng Steve, Diahn-Warng; Mahboub, Bassam; Wang, Eileen; Goh, Celine; Lyu, Juntao; Newell, Anthony; Alacqua, Marianna; Belevskiy, Andrey S; Bhutani, Mohit; Bjermer, Leif; Björnsdóttir, Unnur Steina; Bourdin, Arnaud; Bulow, Anna von; Busby, John; Canonica, Giorgio Walter; Cosio, Borja G; Dorscheid, Delbert R; Muñoz-Esquerre, Mariana; FitzGerald, J Mark; Gil, Esther Garcia; Gibson, Peter G; Heaney, Liam G; Hew, Mark; Hilberg, Ole; Hoyte, Flavia; Jackson, David J; Koh, Mariko Siyue; Ko, Hsin-Kuo Bruce; Lee, Jae Ha; Lehmann, Sverre; Chaves Loureiro, Cláudia; Lúðvíksdóttir, Dóra; Menzies-Gow, Andrew N; Mitchell, Patrick; Papaioannou, Andriana I; Popov, Todor A; Porsbjerg, Celeste M; Salameh, Laila; Sirena, Concetta; Taillé, Camille; Taube, Christian; Tohda, Yuji; Wechsler, Michael E; Price, David B (2023-07)
    BACKGROUND: Patients with severe asthma may present with characteristics representing overlapping phenotypes, making them eligible for more than one class of biologic. Our aim was to describe the profile of adult patients with severe asthma eligible ...
  • Icon
    Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma 
    Porsbjerg, Celeste M; Menzies-Gow, Andrew N; Tran, Trung N; Murray, Ruth B; Unni, Bindhu; Audrey Ang, Shi Ling; Alacqua, Marianna; Al-Ahmad, Mona; Al-Lehebi, Riyad; Altraja, Alan; Belevskiy, Andrey S; Björnsdóttir, Unnur Steina; Bourdin, Arnaud; Busby, John; Canonica, G Walter; Christoff, George C; Cosio, Borja G; Costello, Richard W; FitzGerald, J Mark; Fonseca, João A; Hansen, Susanne; Heaney, Liam G; Heffler, Enrico; Hew, Mark; Iwanaga, Takashi; Jackson, Daniel J; Kocks, Janwillem W H; Kallieri, Maria; Bruce Ko, Hsin-Kuo; Koh, Mariko Siyue; Larenas-Linnemann, Désirée; Lehtimäki, Lauri A; Loukides, Stelios; Lugogo, Njira; Maspero, Jorge; Papaioannou, Andriana I; Perez-de-Llano, Luis; Pitrez, Paulo Márcio; Popov, Todor A; Rasmussen, Linda M; Rhee, Chin Kook; Sadatsafavi, Mohsen; Schmid, Johannes; Siddiqui, Salman; Taillé, Camille; Taube, Christian; Torres-Duque, Carlos A; Ulrik, Charlotte; Upham, John W; Wang, Eileen; Wechsler, Michael E; Bulathsinhala, Lakmini; Carter, Victoria; Chaudhry, Isha; Eleangovan, Neva; Hosseini, Naeimeh; Rowlands, Mari-Anne; Price, David B; van Boven, Job F M (2022-05)
    BACKGROUND: Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for personalized medicine. OBJECTIVE: To compare global differences in ease of access to biologics. ...